MVP and POT1

  • Number of citations of the paper that reports this interaction (PMID 21988832)
  • 14
  • Data Source:
  • BioGRID (two hybrid)

MVP

POT1

Gene Name major vault protein protection of telomeres 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 57 interactors: ADAMTSL4 AES BANP BZRAP1 C1orf94 CALCOCO2 CAMK2B CCDC36 CKAP4 CYTB DISC1 DLX2 EPHX2 ESR1 FAM154A FAM46C GIT2 GOLGA2 HP KCTD9 KPNA2 KPNA3 MDFI MEOX1 MEOX2 MID2 MKL1 NNT NOTCH2NL OBFC1 PARP4 PIH1D2 PLSCR1 POT1 PSTPIP1 PTEN PTPN11 RAB3IP RBPMS REL RHOXF2 RIMBP3 RNF111 SERTAD1 SKIL SLC2A4 TCF4 TFCP2 TP53 TRAF2 TRIM27 TRIM42 TRIP13 TRIP6 VAC14 ZBTB32 ZMIZ2 166 interactors: ACD ACOT7 ACTB ACTN4 ACY1 AFAP1L2 AHCY AHNAK AIPL1 ALDH1A1 ALDH3A1 AMPD2 ANKMY2 ANXA2 ANXA4 APPL2 ARHGDIA ARID3B ARRB1 BAG3 BCAS2 BIN2 C15orf57 C2orf74 CALD1 CAMK1D CCDC9 CCM2 CFL1 CFL2 CKB CLIC3 CNST CORO1A COX6A2 CPNE3 CPPED1 CRK CRYGS CSNK2B CYP4F11 DBN1 DBNL DCX DDX19B DNPH1 DOK2 DPP3 DPYSL3 ECI1 EEF1D EIF3G EIF4B ENO2 ENSA EPB41L1 EVL FAM131B FBP1 FES GAMT GAPDH GAS2L1 GFPT2 GNMT GPA33 GPR52 GRN HAAO HLCS HMOX1 HNMT HOXA3 HSP90AB1 HSPA1A IFRD2 IL1RN ISYNA1 IVL KHDRBS1 KIAA1191 KRT18 LAMC3 LASP1 LDHA LDHB MADD MAGEA4 MAP4 MAP4K2 MAP7 MDM2 MICA MT1X MVK MVP MYO5C NAP1L1 NCDN NOL3 NUDC NUDCD2 NXNL1 PACSIN1 PACSIN2 PAGE2 PAGE5 PAK4 PALM PCP4 PDE1B PDLIM2 PEX5 PFKP PGLS PGM1 PGM2 PHYHD1 PHYKPL PIPOX PRMT7 PROSER2 RBKS RECQL4 RGS14 RIF1 RPAP1 RPSA RTN4 SARS SBDS SERTAD1 SH3BP1 SNCG STIP1 STUB1 SULT1B1 SULT1C2 SULT4A1 SYAP1 TAGLN TBCD TERF1 TERF2 TINF2 TMSB10 TMSB4Y TNKS TOMM34 TPI1 TPP1 TRIM16 TRIP10 TUBB2A TUBB4B TWF2 WIBG WIPI2 XAGE2 YWHAE YWHAG ZBED2 ZBTB49 ZFP36L1 ZNF32 ZNF790
Entrez ID 9961 25913
HPRD ID 05475 07572
Ensembl ID ENSG00000013364 ENSG00000128513
Uniprot IDs B4DP93 Q14764 A8MTK3 Q5MJ33 Q9NUX5
PDB IDs 1Y7X 1XJV 3KJO 3KJP
Enriched GO Terms of Interacting Partners?
Tagcloud ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
0mug  celltiter  chemosensitivity  ddp  downregulate  fluorescein  formerly  gastroesophageal  gc  iodide  isothiocyanate  junction  n87  nci  oncological  oxa  oxaliplatin  performing  pip  platinum  propodium  ptop  telomere  telomeric  tint1  tpp1  trastuzumab  trf2  trf2ip 
Tagcloud (Difference) ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
0mug  celltiter  chemosensitivity  ddp  downregulate  fluorescein  formerly  gastroesophageal  gc  iodide  isothiocyanate  junction  n87  nci  oncological  oxa  oxaliplatin  performing  pip  platinum  propodium  ptop  telomere  telomeric  tint1  tpp1  trastuzumab  trf2  trf2ip 
Tagcloud (Intersection) ?